 Insulin-Secreting Cells
"Insulin-Secreting Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
| Descriptor ID |
D050417
|
| MeSH Number(s) |
A03.734.414.131 A06.390.131 A06.407.414.087 A11.382.625.092 A11.436.294.092
|
| Concept/Terms |
Insulin-Secreting Cells- Insulin-Secreting Cells
- Cell, Insulin-Secreting
- Cells, Insulin-Secreting
- Insulin Secreting Cells
- Insulin-Secreting Cell
- beta Cells, Pancreatic
- Pancreatic beta Cell
- beta Cell, Pancreatic
- Pancreatic B Cells
- B Cell, Pancreatic
- B Cells, Pancreatic
- Pancreatic B Cell
- Pancreatic beta Cells
|
Below are MeSH descriptors whose meaning is more general than "Insulin-Secreting Cells".
Below are MeSH descriptors whose meaning is more specific than "Insulin-Secreting Cells".
This graph shows the total number of publications written about "Insulin-Secreting Cells" by people in UAMS Profiles by year, and whether "Insulin-Secreting Cells" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 0 | 1 | | 2020 | 1 | 1 | 2 | | 2019 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2015 | 1 | 1 | 2 | | 2012 | 2 | 0 | 2 | | 2011 | 1 | 1 | 2 | | 2009 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin-Secreting Cells" by people in Profiles over the past ten years.
-
McDonald S, Ray P, Bunn RC, Fowlkes JL, Thrailkill KM, Popescu I. Heterogeneity and altered ?-cell identity in the TallyHo model of early-onset type 2 diabetes. Acta Histochem. 2022 Oct; 124(7):151940.
-
Tosur M, Cleves MA, Sosenko JM, Libman I, Baidal DA, Balasubramanyam A, Redondo MJ. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. J Clin Endocrinol Metab. 2020 12 01; 105(12).
-
Ismail HM, Cleves MA, Xu P, Libman IM, Becker DJ, Marks JB, Skyler JS, Palmer JP, Sosenko JM. The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study. Diabetes Care. 2020 11; 43(11):2668-2674.
-
Orujov M, Lai KK, Forse CL. Concurrent Adult-Onset Diffuse ?-Cell Nesidioblastosis and Pancreatic Neuroendocrine Tumor: A Case Report and Review of the Literature. Int J Surg Pathol. 2019 Dec; 27(8):912-918.
-
Moonschi FH, Hughes CB, Mussman GM, Fowlkes JL, Richards CI, Popescu I. Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells. Acta Diabetol. 2018 May; 55(5):405-418.
-
B?lici S, Susman S, Rusu D, Nicula GZ, Soritau O, Rusu M, Biris AS, Matei H. Differentiation of stem cells into insulin-producing cells under the influence of nanostructural polyoxometalates. J Appl Toxicol. 2016 Mar; 36(3):373-84.
-
Godinho R, Mega C, Teixeira-de-Lemos E, Carvalho E, Teixeira F, Fernandes R, Reis F. The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class? J Diabetes Res. 2015; 2015:806979.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|